{"id":449204,"title":"Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104) - Summary - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T18:32:26.421000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidelines-active-pharmaceutical-ingredients-0104.html?wbdisable=false","snippet":"Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104) - Summary Guidance on Drug Establishment Licences (GUI-0002) Guidance: How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080) Risk classification…","rawSnapshotUrl":"/api/snapshots/raw/449204","browseUrl":"https://replay.healtharchive.ca/job-6/20260103183226/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidelines-active-pharmaceutical-ingredients-0104.html?wbdisable=false#ha_snapshot=449204","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}